Sorry if I missed the discussion, and I am not trying to start any flame wars..
I have a legitimate concern that it appears $stem has jumped us in line, and appears to have better funding overall for the duration of trials, plus they are not using hesc, which gives them the public opinion advantage as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.